Top compounds associated with response to MYO5B


Feature Type Standardized
Nominal ANOVA
mRNA austocystin d CTRPv2 pan-cancer AAC 0.34 2e-16
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 6e-06
mRNA BRD-K52037352 CTRPv2 pan-cancer AAC 0.2 3e-05
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 4e-05
mRNA Gemcitabine gCSI pan-cancer AAC -0.26 5e-05
mRNA Doxorubicin gCSI pan-cancer AAC -0.24 5e-05
mRNA neratinib CTRPv2 pan-cancer AAC 0.16 7e-05
mRNA Erlotinib gCSI pan-cancer AAC 0.25 9e-05
mRNA PD 153035 CTRPv2 pan-cancer AAC 0.2 9e-05
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 9e-05
Download CSV